glp-1 shortages news november 2025 FDA's decision kicks off 'unprecedented' tussle over shortage glp-1 shortage news november 2025

removing vials from the carton and storing them on an open shelf under fluorescent or natural light is a documented degradation accelerant

doi: 10.3389/fimmu.2022.872458 99 QiFLiuFGaoL

Formulated for superior absorption and intracellular delivery, this is not just skincare - its skin repair at the cellular level

Pathologic Characteristics of Spitz Melanoma With MPA3K8 Fusion or Truncated in a Pediatric Cohort

Srivastava A, Lusby EW, Berns KI

Oral GLP-1 currently represented by Rybelsus (oral semaglutide 7mg/14mg daily) for T2DM and advanced by Eli Lilly's orforglipron in late-stage trials is growing at the fastest route of administration CAGR because it fundamentally removes the injection barrier that constrains GLP-1 therapy adoption in the substantial patient population for whom daily or weekly self-injection is a genuine disincentive to treatment initiation or maintenance